New treatment available for children with severe Psoriasis

Around 22,000 children and young people in England and Wales live with psoriasis, a chronic skin condition that can greatly impact their quality of life.

Now they’ve access to a new treatment on the NHS following a recommendation from the National Institute for Health and Care Excellence (NICE).

Novartis Cosentyx® ( pronounced co-sen- ticks) is an option for treating moderate to severe  ‘plaque psoriasis ‘ in children and young people aged 6 to 17 years who have not responded to other forms of treatment.

Aston spoke to dermatologist Dr Anthony Bewley.